论文部分内容阅读
近几年问,抗菌药物的开发得到进一步发展,以羧苄青档素二钠类为代表的广谱抗菌药物,已广泛用于复杂尿路感染疾患(C-UTI)的治疗。另方面,由于治疗对象本身存在难治性因素的情况更多,即使靠抗菌剂消除了细菌,但发生菌群失调而另外检出霉菌的频率却在增加。一、发生UTI的背景和真菌分离情况单纯性UTI病例偶尔也会从尿中持续检出霉菌,但绝大多数都同时存在严重基础疾总和并发症等背景,主要是抗菌素应用、尿管留置、尿路不畅、尿流改道术后、糖尿病、糖皮质激素应用及恶性肿瘤晚期等。各医疗单位的霉菌分离率有很大差异,大约占住
In recent years, the development of antimicrobial agents has been further developed. Broad spectrum antimicrobial agents represented by carboxybenzylidene disodium have been widely used in the treatment of complicated urinary tract infections (C-UTI). On the other hand, there are more refractory factors in the treatment subject itself. Even if the bacteria are eliminated by the antibacterial agent, there is an increase in the frequency of occurrence of mold disorders in addition to the detection of molds. First, the occurrence of UTI background and the separation of fungi Simple UTI cases occasionally from the urine to detect mold, but the vast majority of the same time there are serious complications and other basic diseases background, mainly antibiotics, catheter indwelling, Poor urinary tract, urinary diversion, diabetes, glucocorticoid use and advanced cancer. The rate of mold isolation varies greatly among medical units, accounting for about 50% of the total